CD47 and cancer: Emerging immunotherapeutic and targeted approaches, including CAR-T cell therapy, PD-1 pathway blockade, CD47-targeted nanotherapeutics, engineered probiotics, and ferroptosis-inducing cancer vaccines, demonstrate substantial promise in brain tumor treatment.